Buprenorphine for Prisoners

Completed · Phase 3

Conditions studied: Heroin Addiction

In brief

This five-year study examines the effectiveness of buprenorphine treatment provided to previously-addicted inmates(N=320; 160 males, 160 females) initiated in prison and continued in the community. The study also examines the extent to which the setting of post-release buprenorphine is provided.It is expected that participants receiving in-prison buprenorphine will have superior outcomes compared to participants who did not receive in-prison buprenorphine.

Key facts

Study ID

NCT00574067

Run by

Friends Research Institute, Inc.

People needed

213

Starts

2008-09-01

Expected to finish

2013-11-01

Last updated by the study team

2018-08-29

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• pre-release prison inmate with 3-6 months remaining until planned release
• history of heroin dependence(meeting DSM-IV criteria of heroin dependence at the time of incarceration and manifesting physical dependence during the year preceding incarceration
• suitability for buprenorphine treatment as determined by medical evaluation
• willingness to participate in the study
• having a Baltimore address and planning to live in Baltimore after release from prison -

You may not qualify if…

• evidence of kidney failure
• evidence of liver failure
• history of psychosis
• having a pending parole hearing
• unadjudicated charges that could result in additional prison time or transfer to another facility -

Where it is running

• Metropolitan Transition Center — Baltimore, Maryland, United States
• Maryland Correctional Institution for Women — Jessup, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.